Literature DB >> 23864239

Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome.

R P E Pollard1, W H Abdulahad, H Bootsma, P M Meiners, F K L Spijkervet, M G Huitema, J G M Burgerhof, A Vissink, F G M Kroese.   

Abstract

Entities:  

Keywords:  B cells; Chemokines; Cytokines; Sjögren's Syndrome; Treatment

Mesh：

Substances：

Year:  2013        PMID： 23864239     DOI： 10.1136/annrheumdis-2013-203447

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Biomarkers: new biomarker for Sjögren's syndrome--time to treat patients.

Authors:  Frans G M Kroese; Hendrika Bootsma
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

2.  sICAM-1 as potential additional parameter in the discrimination of the Sjögren syndrome and non-autoimmune sicca syndrome: a pilot study.

Authors:  Auksė Zinkevičienė; Irena Dumalakienė; Diana Mieliauskaitė; Rita Vilienė; Ieva Narkevičiūtė; Irutė Girkontaitė
Journal:  Clin Rheumatol       Date:  2019-05-31       Impact factor: 2.980

3.  Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients.

Authors:  Annie Visser; Marieke E Doorenspleet; Niek de Vries; Fred K L Spijkervet; Arjan Vissink; Richard J Bende; Hendrika Bootsma; Frans G M Kroese; Nicolaas A Bos
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

4.  Salivary Gland Stem Cells Age Prematurely in Primary Sjögren's Syndrome.

Authors:  Sarah Pringle; Xiaoyan Wang; Gwenny M P J Verstappen; Janneke H Terpstra; Clarence K Zhang; Aiqing He; Vishal Patel; Rhiannon E Jones; Duncan M Baird; Fred K L Spijkervet; Arjan Vissink; Hendrika Bootsma; Robert P Coppes; Frans G M Kroese
Journal:  Arthritis Rheumatol       Date:  2019-01       Impact factor: 10.995

Review 5.  Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.

Authors:  Carlos Rafael-Vidal; Nair Pérez; Irene Altabás; Samuel Garcia; Jose M Pego-Reigosa
Journal:  Int J Mol Sci       Date:  2020-09-26       Impact factor: 5.923

Review 6.  New developments in Sjogren's syndrome.

Authors:  Nishanthi Thalayasingam; Kelly Baldwin; Claire Judd; Wan-Fai Ng
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.046
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.